nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS1—ulcerative colitis	0.224	0.636	CbGaD
Niflumic Acid—PLA2G1B—Sulfasalazine—ulcerative colitis	0.145	0.247	CbGbCtD
Niflumic Acid—PTGS2—ulcerative colitis	0.128	0.364	CbGaD
Niflumic Acid—PLA2G1B—Betamethasone—ulcerative colitis	0.124	0.212	CbGbCtD
Niflumic Acid—PLA2G1B—Dexamethasone—ulcerative colitis	0.0723	0.123	CbGbCtD
Niflumic Acid—PTGS2—Olsalazine—ulcerative colitis	0.0377	0.0644	CbGbCtD
Niflumic Acid—PTGS2—Balsalazide—ulcerative colitis	0.0336	0.0574	CbGbCtD
Niflumic Acid—PTGS1—Olsalazine—ulcerative colitis	0.0319	0.0544	CbGbCtD
Niflumic Acid—PTGS1—Balsalazide—ulcerative colitis	0.0284	0.0485	CbGbCtD
Niflumic Acid—PTGS2—Mesalazine—ulcerative colitis	0.0269	0.0459	CbGbCtD
Niflumic Acid—PTGS1—Mesalazine—ulcerative colitis	0.0227	0.0388	CbGbCtD
Niflumic Acid—PTGS2—Sulfasalazine—ulcerative colitis	0.015	0.0256	CbGbCtD
Niflumic Acid—PTGS2—Triamcinolone—ulcerative colitis	0.015	0.0256	CbGbCtD
Niflumic Acid—PTGS2—Betamethasone—ulcerative colitis	0.0129	0.022	CbGbCtD
Niflumic Acid—PTGS1—Sulfasalazine—ulcerative colitis	0.0127	0.0217	CbGbCtD
Niflumic Acid—PTGS2—Dexamethasone—ulcerative colitis	0.0075	0.0128	CbGbCtD
Niflumic Acid—CLCNKA—digestive system—ulcerative colitis	0.00284	0.188	CbGeAlD
Niflumic Acid—CLCNKA—liver—ulcerative colitis	0.00212	0.14	CbGeAlD
Niflumic Acid—PLA2G1B—epithelium—ulcerative colitis	0.00148	0.0977	CbGeAlD
Niflumic Acid—PLA2G1B—digestive system—ulcerative colitis	0.00112	0.0743	CbGeAlD
Niflumic Acid—Floctafenine—PTGS1—ulcerative colitis	0.00109	0.458	CrCbGaD
Niflumic Acid—UGT1A9—digestive system—ulcerative colitis	0.00103	0.068	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—ulcerative colitis	0.000866	0.0573	CbGeAlD
Niflumic Acid—SLC16A1—epithelium—ulcerative colitis	0.000792	0.0524	CbGeAlD
Niflumic Acid—UGT1A9—liver—ulcerative colitis	0.000765	0.0507	CbGeAlD
Niflumic Acid—SLC16A7—liver—ulcerative colitis	0.000705	0.0467	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—ulcerative colitis	0.000624	0.262	CrCbGaD
Niflumic Acid—SLC16A1—digestive system—ulcerative colitis	0.000602	0.0399	CbGeAlD
Niflumic Acid—SLC16A1—liver—ulcerative colitis	0.000449	0.0297	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS1—ulcerative colitis	0.000426	0.179	CrCbGaD
Niflumic Acid—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000413	0.155	CbGdCrCtD
Niflumic Acid—PTGS1—epithelium—ulcerative colitis	0.000355	0.0235	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—ulcerative colitis	0.000342	0.0226	CbGeAlD
Niflumic Acid—PTGS2—epithelium—ulcerative colitis	0.000339	0.0225	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—ulcerative colitis	0.000327	0.0216	CbGeAlD
Niflumic Acid—PTGS1—digestive system—ulcerative colitis	0.00027	0.0179	CbGeAlD
Niflumic Acid—PTGS2—lymphoid tissue—ulcerative colitis	0.000261	0.0173	CbGeAlD
Niflumic Acid—PTGS2—digestive system—ulcerative colitis	0.000258	0.0171	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—ulcerative colitis	0.000244	0.102	CrCbGaD
Niflumic Acid—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.0002	0.075	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000197	0.0738	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000197	0.0738	CbGdCrCtD
Niflumic Acid—PTGS2—liver—ulcerative colitis	0.000192	0.0127	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000192	0.0721	CbGdCrCtD
Niflumic Acid—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000144	0.00349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Opioid Signalling—ADCY5—ulcerative colitis	0.000142	0.00342	CbGpPWpGaD
Niflumic Acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000141	0.00342	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000138	0.00333	CbGpPWpGaD
Niflumic Acid—SLC16A1—Cell surface interactions at the vascular wall—MMP1—ulcerative colitis	0.000137	0.00332	CbGpPWpGaD
Niflumic Acid—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000133	0.00323	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Budesonide—ulcerative colitis	0.00013	0.0489	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Budesonide—ulcerative colitis	0.00013	0.0489	CbGdCrCtD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.000126	0.00304	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000125	0.00302	CbGpPWpGaD
Niflumic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000124	0.003	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000123	0.00297	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000122	0.00296	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000122	0.00295	CbGpPWpGaD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000122	0.00295	CbGpPWpGaD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000121	0.00292	CbGpPWpGaD
Niflumic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000121	0.0452	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000119	0.0445	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000119	0.0445	CbGdCrCtD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000118	0.00286	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGF Pathway—STAT3—ulcerative colitis	0.000116	0.00281	CbGpPWpGaD
Niflumic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000116	0.0435	CbGdCrCtD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000113	0.00273	CbGpPWpGaD
Niflumic Acid—SLC16A7—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000112	0.00272	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000109	0.00263	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000109	0.00263	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000109	0.00263	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—JAK2—ulcerative colitis	0.000108	0.00261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—ulcerative colitis	0.000107	0.00259	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CHP1—ulcerative colitis	0.000107	0.00258	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000106	0.00256	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—JAK2—ulcerative colitis	0.000104	0.00251	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—RELA—ulcerative colitis	0.000101	0.00244	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000101	0.00243	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.0001	0.00243	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.0001	0.00242	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	9.83e-05	0.00238	CbGpPWpGaD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	9.75e-05	0.00236	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	9.67e-05	0.00234	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	9.59e-05	0.00232	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	9.46e-05	0.00229	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	9.39e-05	0.00227	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—DLD—ulcerative colitis	9.22e-05	0.00223	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	9.14e-05	0.00221	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—ulcerative colitis	9.04e-05	0.00219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	8.74e-05	0.00211	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MMP9—ulcerative colitis	8.58e-05	0.00208	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.52e-05	0.00206	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—NFKB1—ulcerative colitis	8.49e-05	0.00205	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	8.33e-05	0.00201	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—GNA12—ulcerative colitis	8.33e-05	0.00201	CbGpPWpGaD
Niflumic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	8.25e-05	0.002	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ITGAL—ulcerative colitis	8.17e-05	0.00198	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	7.83e-05	0.00189	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	7.82e-05	0.00189	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	7.74e-05	0.00187	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	7.64e-05	0.00185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—STAT3—ulcerative colitis	7.63e-05	0.00185	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	7.3e-05	0.00177	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	7.21e-05	0.00174	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	7.2e-05	0.00174	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	6.85e-05	0.00166	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	6.83e-05	0.00165	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.78e-05	0.00164	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	6.7e-05	0.00162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Hydrocortisone—ulcerative colitis	6.67e-05	0.0251	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Hydrocortisone—ulcerative colitis	6.67e-05	0.0251	CbGdCrCtD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.56e-05	0.00159	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—GNA12—ulcerative colitis	6.48e-05	0.00157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ITGAL—ulcerative colitis	6.36e-05	0.00154	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	6.35e-05	0.00154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Methylprednisolone—ulcerative colitis	6.3e-05	0.0236	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Methylprednisolone—ulcerative colitis	6.3e-05	0.0236	CbGdCrCtD
Niflumic Acid—SLC16A1—Metabolism—CHP1—ulcerative colitis	6.25e-05	0.00151	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—JAK2—ulcerative colitis	6.24e-05	0.00151	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	6.21e-05	0.0015	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Dexamethasone—ulcerative colitis	6.2e-05	0.0233	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Betamethasone—ulcerative colitis	6.2e-05	0.0233	CbGdCrCtD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	6.08e-05	0.00147	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	6.07e-05	0.00147	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Triamcinolone—ulcerative colitis	6.06e-05	0.0227	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Triamcinolone—ulcerative colitis	6.06e-05	0.0227	CbGdCrCtD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	6e-05	0.00145	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—CALM3—ulcerative colitis	5.79e-05	0.0014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisone—ulcerative colitis	5.75e-05	0.0216	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisone—ulcerative colitis	5.75e-05	0.0216	CbGdCrCtD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.72e-05	0.00138	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	5.71e-05	0.00138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisolone—ulcerative colitis	5.61e-05	0.0211	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisolone—ulcerative colitis	5.61e-05	0.0211	CbGdCrCtD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.48e-05	0.00132	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	5.4e-05	0.00131	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—DLD—ulcerative colitis	5.4e-05	0.00131	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	5.25e-05	0.00127	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	5.19e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.88e-05	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.88e-05	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CHP1—ulcerative colitis	4.86e-05	0.00118	CbGpPWpGaD
Niflumic Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	4.8e-05	0.00116	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	4.76e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	4.73e-05	0.00114	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	4.71e-05	0.00114	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	4.62e-05	0.00112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—STAT3—ulcerative colitis	4.58e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.56e-05	0.0011	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.56e-05	0.0011	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	4.52e-05	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CALM3—ulcerative colitis	4.51e-05	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCR1—ulcerative colitis	4.5e-05	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS1—ulcerative colitis	4.46e-05	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	4.42e-05	0.00107	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.39e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	4.36e-05	0.00105	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	4.35e-05	0.00105	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	4.29e-05	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	4.25e-05	0.00103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DLD—ulcerative colitis	4.2e-05	0.00102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.18e-05	0.00101	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.1e-05	0.000991	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CHP1—ulcerative colitis	4.03e-05	0.000974	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CALM3—ulcerative colitis	4.01e-05	0.000971	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.95e-05	0.000956	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL20—ulcerative colitis	3.95e-05	0.000956	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.9e-05	0.000943	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	3.88e-05	0.000938	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.84e-05	0.000928	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.77e-05	0.000913	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MMP1—ulcerative colitis	3.72e-05	0.0009	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GNA12—ulcerative colitis	3.72e-05	0.000899	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.64e-05	0.00088	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.63e-05	0.000878	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.62e-05	0.000875	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	3.54e-05	0.000857	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCR2—ulcerative colitis	3.52e-05	0.000852	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DLD—ulcerative colitis	3.48e-05	0.000841	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.45e-05	0.000834	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	3.44e-05	0.000831	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR6—ulcerative colitis	3.31e-05	0.000801	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CHP1—ulcerative colitis	3.28e-05	0.000794	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SEL1L—ulcerative colitis	3.23e-05	0.000781	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	3.2e-05	0.000773	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ABCB1—ulcerative colitis	3.12e-05	0.000755	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CHP1—ulcerative colitis	3.11e-05	0.000753	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	3.11e-05	0.000751	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	3.07e-05	0.000742	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	3.05e-05	0.000739	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.02e-05	0.000731	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PTGER4—ulcerative colitis	2.92e-05	0.000705	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ADCY5—ulcerative colitis	2.91e-05	0.000704	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MMP1—ulcerative colitis	2.89e-05	0.0007	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	2.89e-05	0.000699	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.86e-05	0.000692	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DLD—ulcerative colitis	2.83e-05	0.000686	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.82e-05	0.000683	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ALB—ulcerative colitis	2.82e-05	0.000682	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	2.81e-05	0.00068	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.69e-05	0.000651	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GHRL—ulcerative colitis	2.67e-05	0.000646	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCR1—ulcerative colitis	2.66e-05	0.000643	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—JAK2—ulcerative colitis	2.62e-05	0.000634	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS1—ulcerative colitis	2.61e-05	0.000631	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CHP1—ulcerative colitis	2.61e-05	0.000631	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CALM3—ulcerative colitis	2.59e-05	0.000625	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.49e-05	0.000602	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SEL1L—ulcerative colitis	2.47e-05	0.000598	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.44e-05	0.000591	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.44e-05	0.00059	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	2.38e-05	0.000576	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CALM3—ulcerative colitis	2.35e-05	0.000568	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL20—ulcerative colitis	2.33e-05	0.000565	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—ulcerative colitis	2.29e-05	0.000553	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	2.27e-05	0.000549	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DLD—ulcerative colitis	2.25e-05	0.000544	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	2.22e-05	0.000538	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.22e-05	0.000537	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LTF—ulcerative colitis	2.22e-05	0.000537	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRB2—ulcerative colitis	2.21e-05	0.000535	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GNA12—ulcerative colitis	2.2e-05	0.000531	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—ulcerative colitis	2.19e-05	0.00053	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PPARG—ulcerative colitis	2.17e-05	0.000525	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCR2—ulcerative colitis	2.08e-05	0.000503	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—JAK2—ulcerative colitis	2.04e-05	0.000493	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS1—ulcerative colitis	2.03e-05	0.000491	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2e-05	0.000483	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.96e-05	0.000474	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR6—ulcerative colitis	1.96e-05	0.000473	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—ulcerative colitis	1.95e-05	0.000472	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.95e-05	0.000471	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADCY5—ulcerative colitis	1.88e-05	0.000454	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAML2—ulcerative colitis	1.85e-05	0.000449	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.84e-05	0.000445	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CALM3—ulcerative colitis	1.83e-05	0.000442	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ABCB1—ulcerative colitis	1.83e-05	0.000442	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	1.8e-05	0.000434	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—ulcerative colitis	1.78e-05	0.000431	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—ulcerative colitis	1.78e-05	0.00043	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.75e-05	0.000422	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTGER4—ulcerative colitis	1.72e-05	0.000417	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—ulcerative colitis	1.71e-05	0.000413	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ADCY5—ulcerative colitis	1.7e-05	0.000412	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS1—ulcerative colitis	1.68e-05	0.000407	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.65e-05	0.0004	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.62e-05	0.000392	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC11A1—ulcerative colitis	1.58e-05	0.000382	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GHRL—ulcerative colitis	1.58e-05	0.000381	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALM3—ulcerative colitis	1.53e-05	0.000369	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CALM3—ulcerative colitis	1.51e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.51e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RIPK2—ulcerative colitis	1.5e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.5e-05	0.000363	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—ulcerative colitis	1.47e-05	0.000355	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.45e-05	0.00035	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ABCB1—ulcerative colitis	1.42e-05	0.000344	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MAML2—ulcerative colitis	1.42e-05	0.000344	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—ulcerative colitis	1.39e-05	0.000335	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.35e-05	0.000326	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.33e-05	0.000323	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ADCY5—ulcerative colitis	1.33e-05	0.000321	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB2—ulcerative colitis	1.31e-05	0.000316	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—ulcerative colitis	1.27e-05	0.000307	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CALM3—ulcerative colitis	1.23e-05	0.000298	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.19e-05	0.000288	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.18e-05	0.000285	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ABCB1—ulcerative colitis	1.18e-05	0.000285	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALM3—ulcerative colitis	1.17e-05	0.000283	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—JAK2—ulcerative colitis	1.17e-05	0.000283	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—ulcerative colitis	1.14e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—ulcerative colitis	1.14e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADCY5—ulcerative colitis	1.11e-05	0.000268	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADCY5—ulcerative colitis	1.1e-05	0.000266	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.09e-05	0.000263	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.07e-05	0.000259	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—ulcerative colitis	1.07e-05	0.000258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—ulcerative colitis	1.02e-05	0.000247	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—ulcerative colitis	1e-05	0.000242	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—ulcerative colitis	9.88e-06	0.000239	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CALM3—ulcerative colitis	9.8e-06	0.000237	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ABCB1—ulcerative colitis	9.6e-06	0.000232	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADCY5—ulcerative colitis	8.95e-06	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—ulcerative colitis	8.89e-06	0.000215	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADCY5—ulcerative colitis	8.49e-06	0.000205	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—ulcerative colitis	8.19e-06	0.000198	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—ulcerative colitis	7.78e-06	0.000188	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCB1—ulcerative colitis	7.62e-06	0.000184	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—ulcerative colitis	7.36e-06	0.000178	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADCY5—ulcerative colitis	7.11e-06	0.000172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JAK2—ulcerative colitis	6.91e-06	0.000167	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RELA—ulcerative colitis	6.69e-06	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—ulcerative colitis	6.68e-06	0.000161	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—ulcerative colitis	6.44e-06	0.000156	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—ulcerative colitis	6.31e-06	0.000153	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—ulcerative colitis	6.03e-06	0.000146	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—ulcerative colitis	6e-06	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—ulcerative colitis	6e-06	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—ulcerative colitis	5.7e-06	0.000138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKB1—ulcerative colitis	5.64e-06	0.000136	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—ulcerative colitis	5.3e-06	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JAK2—ulcerative colitis	5.29e-06	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—ulcerative colitis	5.25e-06	0.000127	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT3—ulcerative colitis	5.07e-06	0.000123	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD4—ulcerative colitis	5.02e-06	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—ulcerative colitis	4.77e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—ulcerative colitis	4.7e-06	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT3—ulcerative colitis	3.88e-06	9.39e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—ulcerative colitis	3.87e-06	9.36e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—ulcerative colitis	3.6e-06	8.71e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—ulcerative colitis	3.54e-06	8.57e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—ulcerative colitis	2.71e-06	6.56e-05	CbGpPWpGaD
